Will Nike Ever Stop Falling? One Analyst is Sure That Buying Now Will Yield 100% Gains
Nike just slipped below its 52-week low while the broader market climbs, but one analyst sees a path to gains that would leave the rest of Wall Street stunned. The question is whether the turnaround math actually works.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nike (NYSE:NKE | NKE Price Prediction) currently trades at $35.10. The average analyst price target stands at $45.63, which implies 30% upside.
Nike is the world’s largest athletic footwear and apparel supplier, now going through a turnaround under CEO Elliott Hill. Piper Sandler analyst Abbie Zvejnieks rates the stock Overweight. Her $75.00 target implies more than 113% upside, far above Wall Street’s consensus.
The gap between consensus and Piper’s target reflects the core debate: one side views a fallen blue chip near its bottom; the other sees a restructuring requiring more time and cost than bulls expect.
A Shrinking Sales Outlook and a China Reset Sent Nike to a 52-Week Low
Nike’s guidance did the most damage. Management expects fiscal 2027 revenue to fall by a high-single-digit percentage, with adjusted EPS of $1.15 to $1.35 versus fiscal 2026 EPS of $2.10. Shares are down 43.44% year to date.
First-quarter revenue fell 4.3% to $11.21 billion, missing the $11.32 billion consensus, though EPS of $0.48 beat the $0.44 estimate. Greater China revenue dropped 22%, Converse fell 28%, and Jordan Brand declined by a mid-teens percentage. Sportswear revenue fell by a low-double-digit percentage after Nike cut Dunk revenue by nearly 50%. Management warned that China “actually gets worse from a revenue perspective for the balance of this year.”
While the sector is weak, Nike is pulling back supply and clearing inventory, making much of this decline company-specific.
Piper Sandler’s $75 Case Rests on Cost Cuts and a Performance Comeback
Piper’s bull case rests on three points:
- Cost cuts that free up $600 million to $1 billion in yearly savings, adding 130 to 200 basis points to operating margin.
- A wholesale restructuring that wins back shelf space at retailers.
- New running and performance shoes that take back share from challenger brands.
Jefferies has also stayed bullish, with a target around the $75 level.
Nike’s Pace restructuring targets about $2.5 billion in total savings through fiscal 2031, with most coming in fiscal 2029 and 2030. Performance business grew by a high-single-digit percentage and running by double digits. Hill called that “a proof point” for the strategy. Nike plans to share a long-term financial framework at its November investor day.
The Street remains largely conservative. Of 39 analysts, one rates Nike a Strong Buy, 10 a Buy, 25 a Hold, one a Sell, and two a Strong Sell. Management also said pain will “bleed in a little bit into fiscal 28,” so recovery will take time.
Deckers Outdoor (NYSE:DECK) has the largest consensus upside in the group, which also includes Lululemon Athletica (NASDAQ:LULU).
Nike Slips Below Its 52-Week Low as the S&P 500 Climbs
At $35.10, Nike stands just under its $35.16 52-week low and far below its $72.39 high. The $45.63 consensus target from 39 analysts implies 30% upside.
Shares fell 7.92% over the past month and 51.13% over the past year, while the S&P 500 gained 12.04% year to date and 14.3% over the past year. Nike trades at about 21 times forward earnings and pays a $0.410 quarterly dividend that management says it can support “under all scenarios.”
Nike’s Recovery Case Is Credible, but $75 Is Years Away
Upside would build if the November investor day lays out a credible path to higher margins, if Pace savings arrive on schedule, and if performance growth offsets cuts in Sportswear and Jordan. The road to $75 runs through wider margins on steady sales.
Risks would mount if China drops beyond fiscal 2027, if Converse keeps shrinking, or if Dunk and Jordan cutbacks leave a gap that performance products can’t fill. Adjusted EPS is guided to $1.15 to $1.35, leaving little room for a guidance cut.
I lean cautiously bullish. The 30% consensus upside looks reachable if Pace delivers. The dividend is backed by $8.4 billion in cash and short-term investments. Piper’s $75 target is the best case, requiring nearly everything to go right.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
